Strong investor demand fails to translate into listing gains as the company’s profitability track record, cash-flow position and aggressive expansion plans remain key concerns
Rays of Belief shares made a flat debut on the BSE and NSE, listing at ₹239 per share, exactly in line with the IPO issue price. The listing was below grey-market expectations, which had indicated a potential premium of around 6 per cent ahead of the debut.
The company’s shares were expected to list near ₹254 based on the prevailing grey market premium. However, the stock opened without any premium or discount, suggesting that investors adopted a cautious approach despite the issue receiving overwhelming demand.
IPO subscribed more than 107 times
The ₹125-crore IPO received bids for approximately 33.79 crore shares against 31.37 lakh shares offered to investors. The issue was subscribed 107.71 times overall, making it one of the most heavily subscribed public offerings in the recent primary-market cycle.
The non-institutional investor category was subscribed 279.11 times, while the retail portion received 195.87 times subscription. The qualified institutional buyer segment was subscribed 9.06 times.
The strong response reflected investor interest in the company’s specialised healthcare services and its expansion opportunity in India and the United States. However, the flat listing highlights the difference between subscription demand and the market’s assessment of a company’s earnings quality and valuation.
Business focused on neurodevelopmental care
Rays of Belief operates under the Mom’s Belief brand and provides personalised intervention programmes for children with neurodevelopmental disorders. Its services cover conditions such as autism spectrum disorder, attention-deficit/hyperactivity disorder, Down syndrome, cerebral palsy, intellectual disabilities, learning disabilities and developmental delays.
The company follows an individualised care model, with intervention plans designed according to the needs of each child. Its expanding centre network across India and the US provides scope for recurring revenue growth as families require long-term therapy and support.
The company’s business operates in a specialised segment where rising awareness, increased diagnosis and growing demand for structured intervention services could support long-term expansion.
IPO proceeds to fund new centres
The IPO comprised an entirely fresh issue of 52.30 lakh equity shares, with the price band fixed at ₹227–239 per share. The minimum application lot consisted of 62 shares, requiring an investment of ₹14,818 at the upper end of the price band.
The company plans to use ₹41.36 crore for setting up new centres. Another ₹14.45 crore has been earmarked for lease payments for existing centres, while ₹10.13 crore will be used for lease and licence payments for its US subsidiary.
The company also intends to spend ₹10.20 crore on brand awareness and outreach programmes. The remaining proceeds will be used for inorganic growth and general corporate purposes.
Rays of Belief had raised ₹50 crore from five anchor investors before the IPO by allotting 20,92,190 shares at ₹239 per share.
Expansion plans bring execution risks
The company has proposed an ambitious expansion programme involving the establishment of 319 new centres between FY27 and FY29. A significant portion of the funds allocated for expansion will be used for centre fit-outs, therapy material inventory and technology hardware.
While the expansion could increase the company’s geographical reach, it also creates execution risks. The company will need to recruit trained professionals, maintain service quality, achieve adequate centre utilisation and control operating costs across multiple locations.
Expansion into the US market could provide additional growth opportunities, but it may also increase regulatory, operational and currency-related risks.
Profitability and cash flow remain concerns
According to analysts, the company’s improving operating margins and growing network are positive factors. However, its relatively short profitability track record and negative operating cash flow in FY26 remain important concerns.
The company’s revenue increased sharply, but profitability declined between FY25 and FY26. Total income rose from ₹36.54 crore in FY25 to ₹82.06 crore in FY26, while profit after tax declined from ₹5.88 crore to ₹4.96 crore. EBITDA improved from ₹3.02 crore to ₹11.91 crore during the same period.
The divergence between revenue growth and net profit indicates that investors will need to monitor cost control, employee expenses, lease costs and the company’s ability to convert accounting profits into operating cash.
Valuation requires strong earnings growth
At the issue price of ₹239, Rays of Belief commanded a valuation that leaves limited room for disappointment. The company’s future valuation will depend on whether it can deliver sustained revenue growth, improve margins and generate positive cash flow.
The absence of directly comparable listed companies also makes it difficult to assess the company’s valuation against established industry peers. Investors may therefore focus more closely on centre-level profitability, revenue per centre, customer retention and the pace of new centre additions.
The flat debut indicates that the market may be seeking stronger evidence of financial sustainability before assigning a higher valuation to the company.
Market Outlook
Rays of Belief’s flat listing despite 107.71 times subscription shows that strong IPO demand does not guarantee listing gains. The company’s long-term prospects will depend on successful centre expansion, improving profitability and consistent operating cash generation.
The stock could remain volatile as investors assess its post-listing valuation and quarterly performance. Sustained improvement in earnings and cash flow may support the stock over the long term, while continued cash burn, slower centre utilisation or execution delays could place pressure on valuations.